News Feed

October 27, 2016 - United win Manchester derby Juan Mata struck to win a tight Man ... +++ October 27, 2016 - IAAF wants Bolt’s services KINGSTON, Jamaica – IAAF Pres ... +++ October 27, 2016 - Proper shutdown protocol needed, says Bynoe The Department of Emergency Managem ... +++ October 27, 2016 - ‘Out of touch’ Economist Ryan Straughn says the la ... +++ October 27, 2016 - Lowe looking to protect the south coast A senior policymaker has warned tha ... +++ October 27, 2016 - Road Hockey 5s hit halfway mark After three weeks of competition th ... +++

GUINEA – Vaccine ‘game-changer’

Preliminary results of trial are ‘remarkable’

CONAKRY –– A vaccine against the deadly Ebola virus has led to 100 per cent protection and could transform the way Ebola is tackled, preliminary results suggest.

There were no proven drugs or vaccines against the virus at the start of the largest outbreak of Ebola in history, which began in Guinea in December, 2013.

The World Health Organization (WHO) said the findings, being published in the Lancet, could be a “game-changer”.

Experts said the results were “remarkable”.

Man being vaccinated against the Ebola virus.

Man being vaccinated against the Ebola virus.

This trial centred on the VSV-EBOV vaccine, which was started by the Public Health Agency of Canada and then developed by the pharmaceutical company Merck.

It combined a fragment of the Ebola virus with another safer virus in order to train the immune system to beat Ebola.

A unique clinical trial took place in Guinea. When a patient was discovered, their friends, neighbours and family were vaccinated to create a “protective ring” of immunity.

One hundred patients were identified in the trial between April and July and then close contacts were either vaccinated immediately, or three weeks later.

In the 2,014 close contacts who were vaccinated immediately there were no subsequent cases of Ebola.

In those vaccinated later there were 16 cases, according to the results published in the Lancet medical journal.

The WHO says it is so far 100 per cent effective, although that figure may change as more data is collected.

Close contacts of Ebola patients in Guinea will now be vaccinated immediately. And since the vaccine has been shown to be safe, that process will also be extended to include children.

Médecins Sans Frontières (MSF) is involved with this research, and is part of a parallel trial for frontline healthcare workers.

Medical director Bertrand Draguez said the Lancet results should spur instant action.

“With such high efficacy, all affected countries should immediately start and multiply ring vaccinations to break chains of transmission and vaccinate all frontline workers to protect them.”

Marie-Paule Kieny, an assistant director general at the WHO told BBC News: “It is certainly promising. We have seen that where rings have been vaccinated, the transmission has stopped.

“Prior to vaccination there were cases, cases, cases. The vaccine arrives and ten days later the cases are flat.

“It could be a game-changer because previously there was nothing, despite the disease being identified 40 years ago.

“When there is a new outbreak this vaccine will be put to use to stop the outbreak as soon as possible to not have the terrible disaster we have now.”

More than 11,000 people have died from Ebola and nearly 28,000 have been infected.

The sheer scale of the 2014-2015 outbreak led to an unprecedented push on vaccines –– and a decade’s work has been condensed into around ten months.

The number of cases has fallen –– and in the week up to July 26, 2015, there were just four cases in Guinea and three in Sierra Leone.

Professor John Edmunds, from the London School of Hygiene & Tropical Medicine, helped design the trial: “The development has been at an absolutely unprecedented speed.

“This is very good news, these are very significant results, the epidemic is not over and this shows we have another potential weapon.

“The trial is still continuing, these are interim results which need confirming, but there’s now light at the end of the tunnel.”

Dr Jeremy Farrar, the director of the Wellcome Trust medical charity, said this was a “remarkable result” and was the product of international collaboration.

He added: “Our hope is that this vaccine will now help bring this epidemic to an end and be available for the inevitable future Ebola epidemics.”

Source: (BBC)

Leave a Reply

Your email address will not be published. Required fields are marked *